Drug information for ATAZANAVIR SULFATE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
300MG
Tentative Approval
ATAZANAVIR SULFATE
atazanavir
EMCURE PHARMS
200196
2010-08-24 Letter
CAPSULE; ORAL
100MG
Tentative Approval
ATAZANAVIR SULFATE
atazanavir
EMCURE PHARMA
78785
2008-02-07 Letter
CAPSULE; ORAL
150MG
Tentative Approval
ATAZANAVIR SULFATE
atazanavir
EMCURE PHARMA
"
CAPSULE; ORAL
200MG
Tentative Approval
ATAZANAVIR SULFATE
atazanavir
EMCURE PHARMA
"
CAPSULE; ORAL
150MG
Tentative Approval
ATAZANAVIR SULFATE
atazanavir
MATRIX LABS LTD
91611
2010-09-20 Letter
CAPSULE; ORAL
100MG
Tentative Approval
ATAZANAVIR SULFATE
atazanavir
TEVA PHARMS USA
91673
CAPSULE; ORAL
150MG
Tentative Approval
ATAZANAVIR SULFATE
atazanavir
TEVA PHARMS USA
"
CAPSULE; ORAL
200MG
Tentative Approval
ATAZANAVIR SULFATE
atazanavir
TEVA PHARMS USA
"
CAPSULE; ORAL
300MG
Tentative Approval
ATAZANAVIR SULFATE
atazanavir
TEVA PHARMS USA
"
Drug Adverse Effects information for ATAZANAVIR SULFATE
Role code
Indications
Reaction
# Reports
SS
HEPATITIS C
CHOLECYSTECTOMY
1
SS
HEPATITIS C
CHOLELITHIASIS
1
SS
HEPATITIS C
PANCREATITIS
1
SS
HIV INFECTION
CHOLECYSTECTOMY
1
SS
HIV INFECTION
CHOLELITHIASIS
1
SS
HIV INFECTION
DRUG INTERACTION
3
SS
HIV INFECTION
PANCREATITIS
1
SS
HIV INFECTION
PANCREATITIS ACUTE
3
SS
HYPERPHOSPHATAEMIA
DRUG INTERACTION
1
SS
HYPERPHOSPHATAEMIA
PANCREATITIS ACUTE
1
SS
HYPERTENSION
DRUG INTERACTION
2
SS
HYPERTENSION
PANCREATITIS ACUTE
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
CHOLECYSTECTOMY
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
CHOLELITHIASIS
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
PANCREATITIS
2
SS
RENAL FAILURE
DRUG INTERACTION
1
SS
RENAL FAILURE
PANCREATITIS ACUTE
1
C
ALCOHOLIC LIVER DISEASE
DIARRHOEA
4
C
ALCOHOLIC LIVER DISEASE
RENAL FAILURE ACUTE
4
C
ALCOHOLIC LIVER DISEASE
RHABDOMYOLYSIS
4
C
ASCITES
DIARRHOEA
3
C
ASCITES
RENAL FAILURE ACUTE
3
C
ASCITES
RHABDOMYOLYSIS
3
C
CEREBROVASCULAR ACCIDENT PROPHYLAXIS
CONJUNCTIVITIS
1
C
CEREBROVASCULAR ACCIDENT PROPHYLAXIS
INFLAMMATION
1
C
CEREBROVASCULAR ACCIDENT PROPHYLAXIS
RASH
1
C
DEPRESSION
CONJUNCTIVITIS
2
C
DEPRESSION
INFLAMMATION
2
C
DEPRESSION
RASH
2
C
GASTRODUODENAL ULCER
HEPATIC FAILURE
1
C
GASTRODUODENAL ULCER
HEPATITIS CHOLESTATIC
1
C
GASTRODUODENAL ULCER
JAUNDICE
1
C
HIV INFECTION
CONJUNCTIVITIS
3
C
HIV INFECTION
DIARRHOEA
7
C
HIV INFECTION
HEPATIC FAILURE
4
C
HIV INFECTION
HEPATITIS CHOLESTATIC
4
C
HIV INFECTION
INFLAMMATION
3
C
HIV INFECTION
JAUNDICE
4
C
HIV INFECTION
PANCYTOPENIA
3
C
HIV INFECTION
RASH
3
C
HIV INFECTION
RENAL FAILURE ACUTE
7
C
HIV INFECTION
RHABDOMYOLYSIS
7
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
DIARRHOEA
1
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
RENAL FAILURE ACUTE
1
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
RHABDOMYOLYSIS
1
C
PRODUCT USED FOR UNKNOWN INDICATION
DIARRHOEA
2
C
PRODUCT USED FOR UNKNOWN INDICATION
RENAL FAILURE ACUTE
2
C
PRODUCT USED FOR UNKNOWN INDICATION
RHABDOMYOLYSIS
2
C
PROPHYLAXIS AGAINST HIV INFECTION
PANCYTOPENIA
1
C
SYPHILIS
DIARRHOEA
1
C
SYPHILIS
RENAL FAILURE ACUTE
1
C
SYPHILIS
RHABDOMYOLYSIS
1
C
TOXOPLASMOSIS PROPHYLAXIS
DIARRHOEA
1
C
TOXOPLASMOSIS PROPHYLAXIS
RENAL FAILURE ACUTE
1
C
TOXOPLASMOSIS PROPHYLAXIS
RHABDOMYOLYSIS
1
I
ABNORMAL BEHAVIOUR
DRUG INTERACTION
1
I
ABNORMAL BEHAVIOUR
ELECTROCARDIOGRAM QT PROLONGED
1
I
ABNORMAL BEHAVIOUR
SEDATION
1
I
HIV INFECTION
DRUG INTERACTION
4
I
HIV INFECTION
ELECTROCARDIOGRAM QT PROLONGED
4
I
HIV INFECTION
SEDATION
4
I
MENTAL DISORDER
DRUG INTERACTION
1
I
MENTAL DISORDER
ELECTROCARDIOGRAM QT PROLONGED
1
I
MENTAL DISORDER
SEDATION
1
I
SCHIZOAFFECTIVE DISORDER
DRUG INTERACTION
4
I
SCHIZOAFFECTIVE DISORDER
ELECTROCARDIOGRAM QT PROLONGED
4
I
SCHIZOAFFECTIVE DISORDER
SEDATION
4
Ads by Google